Table 2 The incidence of MAC-pulmonary disease-associated events, MAC-specific mortality, and all-cause mortality.
From: Effect of multidrug therapy on the prognosis of Mycobacterium avium complex pulmonary disease
Multidrug therapy group (n = 90) | Observation group (n = 108) | Relative risk (95% CI) | |
|---|---|---|---|
Incidence of MAC-PD associated events, /1000 person-years | |||
All events | 26.69 | 25.49 | 1.05 (0.61–1.79) |
Hospitalisation for haemoptysis | 4.85 | 6.37 | 0.76 (0.23–2.47) |
Hospitalisation for respiratory infections | 12.13 | 15.29 | 0.79 (0.38–1.68) |
Chronic respiratory failure | 9.71 | 3.82 | 2.54 (0.78–8.28) |
MAC-specific mortality, /1000 person-years | 12.13 | 12.74 | 0.92 (0.44–2.08) |
All-cause mortality, /1000 person-years | 24.26 | 29.50 | 0.82 (0.48–1.40) |
